Jupiter Hospital and MedGenome Labs have launched the Jupiter–MedGenome Genomics Lab to strengthen access to genomic testing in Mumbai.
The laboratory will support next-generation sequencing (NGS) for cancer care, rare genetic disorders, prenatal testing, and disease diagnosis.
The initiative will integrate genomic diagnostics into routine clinical care, supporting more informed treatment decisions.
Mumbai-based Jupiter Hospital has partnered with MedGenome Labs to launch the Jupiter–MedGenome Genomics Lab, expanding access to genomic diagnostics for patients and clinicians in the region. The laboratory will offer genetic testing for disease diagnosis, risk assessment, treatment selection, and prenatal care, bringing advanced genomic services closer to routine clinical practice. The initiative expands access to specialized genomic testing across Western India and supports precision medicine in clinical practice.
The newly launched Jupiter–MedGenome Genomics Lab will provide genomic testing for disease diagnosis, genetic risk assessment, treatment selection, and prenatal care. By offering these services within the hospital, the facility is expected to help clinicians access genetic insights sooner and use them to guide patient care.
Speaking about the collaboration, Dr. Avi Nahar, Chief Commercial Officer and Senior Vice President of Sales at MedGenome Labs, said, "Jupiter-MedGenome Genomics Lab marks a shift from genomics-as-referral to genomics-as-infrastructure."
He added, "On-site NGS capability means oncology panels, rare disease exomes, and prenatal testing feed directly into clinical decision-making, cutting turnaround time and reducing the friction between a genetic finding and a treatment change."
Genomic testing analyzes a person's DNA to identify genetic changes linked to inherited disorders, certain cancers, and other medical conditions. The results can help doctors confirm diagnoses, assess disease risk, choose targeted therapies, and tailor treatment to each patient's genetic makeup.
Next-generation sequencing (NGS), which the new laboratory will offer, can examine multiple genes in a single test. The technology is widely used in cancer care, prenatal testing, and the diagnosis of rare genetic disorders, helping clinicians make faster treatment decisions. Dr. Avi Nahar, Chief Commercial Officer and Senior Vice President of Sales at MedGenome Labs, said this enables "variant-level insight informing therapy selection in real time, not weeks later.
The collaboration builds on MedGenome's recent expansion of its diagnostic network in Western India. Earlier, Medcare Diagnostics, part of MedGenome's integrated diagnostics ecosystem, launched an imaging and nuclear medicine centre in Navi Mumbai, bringing imaging, nuclear medicine, and genomic testing services together under one network.
The launch of the Jupiter–MedGenome Genomics Lab further expands access to hospital-based genomic diagnostics in the region.
The new laboratory adds hospital-based genomic testing to MedGenome's growing diagnostic network in Western India, supporting broader use of precision medicine in clinical care.
(Rh/TP/MSM)